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A B S T R A C T
MicroRNAs regulate developmental events such as branching morphogenesis, epithelial to mesenchymal transition (EMT) and its reverse process mesenchymal to
epithelial transition (MET). In this study, we performed small RNA sequencing of a breast epithelial progenitor cell line (D492), and its mesenchymal derivative
(D492M) cultured in three-dimensional microenvironment. Among the most downregulated miRNAs in D492M was miR-203a, a miRNA that plays an important role
in epithelial differentiation. Increased expression of miR-203a was seen in D492, concomitant with increased complexity of branching. When miR-203a was
overexpressed in D492M, a partial reversion towards epithelial phenotype was seen. Gene expression analysis of D492M and D492MmiR-203a revealed peroxidasin, a
collagen IV cross-linker, as the most significantly downregulated gene in D492MmiR-203a. Collectively, we demonstrate that miR-203a expression temporally cor-
relates with branching morphogenesis and is suppressed in D492M. Overexpression of miR-203a in D492M induces a partial MET and reduces the expression of
peroxidasin. Furthermore, we demonstrate that miR-203a is a novel repressor of peroxidasin. MiR-203-peroxidasin axis may be an important regulator in branching
morphogenesis, EMT/MET and basement membrane remodeling.
Summary statement
MiR-203a is highly upregulated during branching morphogenesis of
D492 breast epithelial progenitor cells and is downregulated in its
isogenic mesenchymal cell line D492M. Furthermore, miR-203a is a
novel suppressor of peroxidasin (PXDN), a collagen IV crosslinking
agent. MiR-203a may be an important regulator of branching mor-
phogenesis and basement remodeling in the human breast gland, pos-
sibly through its target PXDN.
1. Introduction
Developmental events underlying breast epithelial morphogenesis
are closely related to pathways important to cancer progression, i.e.
epithelial to mesenchymal transition (EMT) and mesenchymal to epi-
thelial transition (MET). Evidence shows that the two distinct epithelial
cell lineages that make up branching morphogenesis in the breast, lu-
minal- and myoepithelial cells, originate from common breast epithelial
stem cells (Pechoux et al., 1999; Gudjonsson et al., 2002; Villadsen
et al., 2007; Petersen and Polyak, 2010). These stem cells are re-
sponsible for continuous tissue remodeling throughout the reproductive
period, as well as the extensive epithelial expansion and branching
morphogenesis seen during pregnancy and lactation. Although, poten-
tial stem or progenitor cells have been identified in the human female
breast gland there is still limited knowledge about the lineage devel-
opment in the human breast. In that respect much can be learned from
linage tracing studies in the mouse mammary gland. Recent studies
have demonstrated that embryonic mammary gland contains homo-
genous basal progenitor cells that become restricted in the postnatal
mammary gland (Lloyd-Lewis et al., 2018). Lilja et al. demonstrated
that embryonic multipotent mammary cells become lineage-restricted
early in development and that gain of function dictates luminal cell fate
specification to both embryonic and basally committed mammary cells
(Lilja et al., 2018). In a recent article Pal et al. demonstrated by single
cell profiling of four developmental stages in the post-natal gland that
the epithelium undergoes large changes in gene expression (Pal et al.,
2017). In this paper they show that homogeneous basal-like expression
pattern in pre-puberty was distinct to lineage-restricted programs in
https://doi.org/10.1016/j.mod.2018.11.002
Received 29 March 2018; Received in revised form 1 November 2018; Accepted 23 November 2018
⁎ Corresponding author at: Stem Cell Research Unit, Department of Medical Faculty, Biomedical Center, University of Iceland, Vatnsmyrarvegi 16, 101 Reykjavík,
Iceland.
E-mail address: tgudjons@hi.is (T. Gudjonsson).
Mechanisms of Development 155 (2019) 34–47
Available online 01 December 2018
0925-4773/ © 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
puberty. Cellular linage tracing in humans is for obvious reasons not
possible. However, transplantation of human breast epithelial cells into
cleared mouse mammary fat pad (Lawson et al., 2015; Wronski et al.,
2015) and 3D culture (Vidi et al., 2013) have to some extend unraveled
the stem cell biology in the human breast gland. D492 is a breast epi-
thelial stem cell line that generates branching in vivo-like structures in
3D-rBM (Gudjonsson et al., 2002; Villadsen et al., 2007; Sigurdsson
et al., 2011). We have previously shown that when D492 is co-cultured
Fig. 1. Profiling miRNAs in the isogenic breast epithelial progenitor cell line D492 and its mesenchymal derivative D492M.
A) Differentially expressed miRNAs between D492M and D492 in 3D culture based on small RNA sequencing. Forty-seven miRNAs are differentially expressed
between the mesenchymal (D492M) and epithelial (D492) state at day 14 in 3D culture. Twenty miRNAs are downregulated in D492M and among them are miRNAs
that are important for epithelial integrity, such as the miR-200 family and miR-203a. Scale bar= 100 μm.
B) Volcano plot showing differential expressed miRNAs in D492M and D492, depicting statistical significance and high fold change in expression of epithelial
associated miRNAs. Volcano plot constructed from small RNA sequencing data using fold change of expression values and p-values, enabling the visualization of the
relationship between fold change and statistical significance. More extreme values on the x-axis show increased differential expression and higher values on the y-axis
show increased statistical significance. The miR-200c-141 locus along with miR-205, miR-944, miR-584, miR-708 and miR-203a show the most fold change and
statistical significance of the miRNAs downregulated in D492M.
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under 3D conditions, breast endothelial cells markedly stimulate their
branching ability, but can also induce an irreversible EMT in the epi-
thelial cells (Sigurdsson et al., 2011). This condition gave rise to the
D492M cell line (Sigurdsson et al., 2011). In EMT, different pathways
ultimately control transcriptional regulatory factors such as SNAI1,
SNAI2, TWIST, ZEB1 and ZEB2 leading to increased expression of me-
senchymal and decreased expression of epithelial markers (Moustakas
and Heldin, 2007). Downregulation of the epithelial cell-cell adhesion
proteins, such as E-cadherin, is one of the hallmarks of EMT (Peinado
et al., 2007). In addition, expression of epithelial specific keratins is
often greatly reduced, while expression of mesenchymal markers, such
as N-cadherin, vimentin, alpha smooth muscle actin and fibronectin are
increased in EMT (Moustakas and Heldin, 2007). Enhanced migration,
invasion and resistance to apoptosis are also characteristic for cells that
have undergone EMT (Hanahan and Weinberg, 2011). The tightly
regulated process of cell conversion seen in EMT is also a critical event
seen in many cancer types, including breast cancer (Petersen et al.,
2001; Mani et al., 2008; Sarrio et al., 2008) and EMT is typically as-
sociated with increased aggressiveness and metastatic behavior
(Hanahan and Weinberg, 2011).
Interestingly, the mesenchymal transition from D492 to D492M is
accompanied by drastic changes in microRNA (miRNA) expression
(Hilmarsdottir et al., 2015). MiRNAs have been described as regulators
of protein expression through their ability to bind and silence mRNAs,
where silencing of certain transcription factors, which are important for
gene regulation, may cause marked changes in cell phenotype and fate
(Hilmarsdottir et al., 2014). In recent years, miRNAs have been shown
to be either tumor promoting or tumor suppressing depending on
context and cancer type. For example, the miR-200 family has been
linked to both stem cell regulation and cancer progression (Shimono
et al., 2009). This family of miRNAs is strongly downregulated in tu-
mors with high metastatic potential (Olson et al., 2009) and miR-200c,
a member of this family, is downregulated in human breast cancer stem
cells and normal mammary stem cells (Shimono et al., 2009). We have
recently shown that the miRNA-200c-141 cluster is predominantly ex-
pressed in luminal breast epithelial cells, and that miRNA-200c-141 is
highly expressed in D492, but not in D492M. Interestingly, over-
expression of miR-200c-141 in D492M restored the luminal epithelial
phenotype (Hilmarsdottir et al., 2015).
In this study, we compared the miRNA expression profile of D492
and D492M, when cultured in 3D reconstituted basement membrane
matrix (3D-rBM). Small RNA sequencing revealed a striking difference
in expression patterns between the two cell lines, with a number of
known epithelial miRNAs, including miR-203a, downregulated in
D492M. We demonstrated that miR-203a expression increases during
branching morphogenesis in vitro similar to its expression pattern in
mouse mammary gland in vivo (Avril-Sassen et al., 2009). Furthermore,
overexpression of miR-203a in D492M induced partial phenotypic
changes towards MET, reduced cell proliferation, migration, invasion,
and increased sensitivity to chemically induced apoptosis. Finally, we
identified miR-203a as a novel repressor of peroxidasin (PXDN), an
extracellular matrix protein with peroxidase activity and a collagen IV
crosslinking agent.
2. Results
2.1. Comparison of miRNA expression in the breast epithelial progenitor cell
line D492 and its mesenchymal derivative D492M
D492 and D492M are isogenic cell lines with epithelial and me-
senchymal phenotypes, respectively. We have previously shown a
profound difference in miRNA expression between these cell lines when
cultured in monolayer (Hilmarsdottir et al., 2015). Here, we conducted
an expression analysis in 3D culture. Due to its stem cell properties,
D492 can generate branching structures in 3D-rBM culture reminiscent
of terminal duct lobular units (TDLUs) in the breast. In contrast, D492M
form disorganized mesenchymal-like structures with spindle shape
protrusions of cells (Fig. 1A, top). To investigate the miRNA expression
patterns between D492 and D492M in 3D-rBM we performed small
RNA sequencing (Fig. 1A). This revealed 47 differentially expressed
miRNAs (> 1.5-fold change, p < 0.05 and FDR < 0.1) between D492
from (days 7, 14 and 21) and D492M at day 14 in 3D culture, where 20
of these miRNAs were downregulated in D492M. Among the most
profound changes was downregulation of miR-200c, miR-141, miR-205
and miR-203a in D492M (Fig. 1A), all of which have been previously
associated with epithelial integrity and repression of EMT (Gregory
et al., 2008; Wellner et al., 2009; Feng et al., 2014). These miRNAs were
all downregulated with high statistical significance in D492M as shown
in the volcano plot (Fig. 1B). The upregulated miRNAs in D492M do not
show as clear involvement in EMT as the downregulated ones.
2.2. Downregulation of miR-203a in D492M is not due to methylation of its
CpG islands in the promoter area
Methylation of CpG islands in promoter areas is a common event
during gene silencing. To further explore what causes downregulation
of miRNAs in D492M, we explored the promoter DNA methylation
status of differentially expressed miRNAs. We used the
HumanMethylation450K BeadChip and looked at CpGs within 5 kb re-
gion of the promoter area of differentially expressed miRNAs. Two
miRNAs did not have probes within the 5 kb region of the gene but of
the 45 which did, 8 miRNAs showed differential DNA methylation be-
tween D492 and D492M (Table S2). Our data shows that promoter
areas upstream of miR-200c-141 and miR-205 were methylated in
D492M, but not in D492 (Fig. 2A). In contrast, the promoter area of
miR-203a was not differentially methylated between D492 and D492M
(Fig. 2A). Bisulfite sequencing of the promoter area of miR-200c-141,
miR-205 and miR-203a confirmed that the promoter of miR-203a was
unmethylated in D492M, unlike the promoters of miR-200c-141 and
miR-205 (Fig. 2B). This is in contrast to previously published results in
human mammary epithelial cells (HMLE) undergoing EMT (Taube
et al., 2013) and some metastatic breast cancer cell lines (Zhang et al.,
2011), where the promoter of miR-203a becomes methylated. Our data
shows that a profound downregulation of miR-203a could be mediated
through other mechanisms than DNA methylation, such as histone
modifications. Indeed, miR-203a expression has been shown to be
suppressed by EZH2 in prostate cancer (Cao et al., 2011). In summary,
the repression of miR-203a, in endothelial induced EMT of D492 is not
due to promoter methylation.
2.3. MiR-203a shows temporal changes in expression during branching
morphogenesis in 3D culture and is associated with luminal breast epithelial
cells
The breast gland is a dynamic organ during the reproduction period.
In each menstrual cycle the breast epithelium undergoes changes as-
sociated with branching morphogenesis and if pregnancy occurs, the
branching epithelium expands resulting in maximal differentiation
during lactation. The glandular epithelium is then subject to apoptosis
after breastfeeding during the involution phase (Javed and Lteif, 2013).
Using D492 breast progenitor cells that are capable of generating
branching epithelial morphogenesis in 3D-rBM, it is possible to analyze
temporal changes during the branching process. To investigate if
changes in miRNA expression occur during formation of TDLU–like
structures in 3D-rBM, we isolated RNA from 3D-rBM cultures at days 7,
14 and 21, and performed small RNA sequencing.
Fifty-five miRNAs were differentially expressed between individual
time points (> 2-fold change, FDR corrected p-value<0.05), thereof
40 miRNAs were downregulated and 15 miRNAs were upregulated
during branching (Fig. 3A). In particular, among the upregulated
miRNAs were miR-141 and miR-203, which were also some of the most
downregulated miRNAs in D492M (Fig. 1A). Thus, small RNA
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sequencing, and subsequent verification with RT-qPCR, demonstrates
that expression of miR-203a and miR-141 increased between time
points and peaked at the late branching stage (day 21) (Fig. 3A–B). In
contrast, expression of miR-205 and miR-200c was constant throughout
the branching process (Fig. 3B). This indicates that miR-203a and miR-
141 may play a role in differentiation of the epithelial cells during
branching morphogenesis. The human breast epithelium is composed of
two epithelial lineages, the luminal epithelial and the myoepithelial
cells. In order to investigate whether miR-203a expression was lineage
specific with either luminal- or myoepithelial cells, we sorted primary
breast epithelial cells with EpCAM positive magnetic beads, as EpCAM
is a luminal associated adhesion molecule that is also highly useful for
antibody-based enrichment of luminal epithelial cells. We measured
miR-203a expression in EpCAM high and EpCAM low cells, and de-
monstrated that, miR-203a expression was predominately associated
with the EpCAM high luminal epithelial cells (Fig. 3C, left). There was
some expression in the EpCAM low/negative myoepithelial cells, but no
or little expression in endothelial cells and fibroblast (Fig. 3C, left). Due
to the bipotential properties of D492 cells, they are able to generate
luminal- and myoepithelial cells and differentiation of D492 branching
colonies, into the two epithelial lineages, is clearly demonstrated with
immunostaining against luminal- and myoepithelial markers
(Gudjonsson et al., 2002). Based on EpCAM sorting of D492 cells into
EpCAM high and EpCAM low fractions, we further confirmed that miR-
Fig. 2. miRNA promoter methylation of D492 and D492M
A) Differential DNA methylation of D492 (red) and D492M (blue). CpG methylation in the promoter area of differentially expressed miRNAs was investigated using
the HumanMethylation450 BeadChip. The yellow bar represents the pre-miRNA and differential methylation is determined by a beta value>0.2. MiR-200c, miR-
141 and miR-205 are differentially methylated with more methylation in D492M, while methylation of miRNA-203a is unchanged. The expression of miR-200c-141
and miR-205 is repressed through DNA methylation, while expression of miRNA-203a is not.
B) Bisulfite sequencing of miRNA promoters in D492 and D492M. The promoters of miR-200c-141, miR-205 and miR-203a are un-methylated in D492. In D492M, the
promoter of miR-203a remains un-methylated, while the promoters of miR-200c-141 and miR-205 are methylated.
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Fig. 3. MiR-203a is differentially expressed
during branching morphogenesis in 3D cul-
ture.
A) Heatmap showing differentially expressed
miRNAs in D492 at different time points
during branching morphogenesis. Small RNA-
sequencing of D492 at three different time
points during branching morphogenesis at day
7, 14 and 21. miR-203a expression increases
during branching of D492. Heatmap shows
miRNAs with>2-fold change in expression
an FDR corrected p-values< 0.1. Scale
bar= 100 μm.
B) Expression of epithelial miRNAs in D492 at
different time points during branching. RT-
qPCR showing that the expression of miR-
203a and miR-141 significantly increases be-
tween time points during branching morpho-
genesis. Interestingly, expression of miR-203a
increases markedly in late branching at day
21.
C) i) Expression of miR-203a in breast primary
cells and D492 EpCAM sorted cells. In primary
cells, miR-203a is expressed in the epithelial
cells and is predominantly associated with the
luminal cells but is absent in fibroblasts and
endothelial cells. In D492 cells, miR-203a ex-
pression is predominantly associated with the
EpCAM High cells.
ii) MiR-203a expression in breast cell lines.
MiR-203a is expressed in breast cell lines with
an epithelial phenotype but not with a me-
senchymal phenotype. Expression of miR-
203a in mesenchymal derivatives of D492 and
HMLE, i.e. D492M and HMLEmes, is down-
regulated with little or no expression in the
mesenchymal state. The normal like breast
cell line MCF10A has high expression of miR-
203a, while the triple negative mesenchymal
breast cancer cell line MDA-MB-231 has no
expression of miR-203a. Results are displayed
as average of three independent experiments
(mean ± sd, n= 3).
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203a was more associated with the luminal epithelial population in
D492 (Fig. 3C, right). Differential expression of miR-203a between
D492 and D492M was confirmed by RT-qPCR (Fig. 3C, right). To de-
termine whether this was in concurrence with other breast cell lines
with epithelial and mesenchymal phenotypes, we examined the ex-
pression levels of miR-203a in HMLE, its mesenchymal derivative
HMLEmes (Fig. 3C, right), the normal cell-derived MCF10A, and the
mesenchymal cancer cell line, MDA-MB-231 (Fig. 3C, right). Expression
of miR-203a was restricted to all three cell lines with an epithelial
phenotype.
2.4. MiR-203a expression reduces the mesenchymal traits of D492M cells
To analyze if the presence of miR-203a affects the phenotype of
D492M, we overexpressed miR-203a in D492M (D492MmiR-203a), using
a lentiviral based transfection system. D492MmiR-203a expressed miR-
203a 17,500-fold higher than control (D492MEmpty) (Fig. 4A). Inter-
estingly, phase contrast images of monolayer cultures show that miR-
203a overexpression in D492M causes increased adherence between
cells (Fig. 4B). Furthermore, when D492M is cultivated in 3D-rBM, it
forms spindle shaped mesenchymal-like colonies in contrast to
D492MmiR-203a that forms more compact colonies although the colonies
still show cellular protrusions, typical of mesenchymal cells (Fig. 4B).
When the cells were cultured in monolayer, overexpression of miR-
203a in D492M reduces the proliferation rate of the cells (Fig. 4C).
Furthermore, there was visible reduction in expression of the me-
senchymal marker N-cadherin and increased expression of E-cadherin,
K14 and K19 in D492MmiR-203a, indicating a moderate reduction in
mesenchymal characteristics (Fig. 4D–E). The EMT transcription factor
SNAI2 is a confirmed target of miR-203a, and miR-203a is in return
suppressed by SNAI2 forming a negative feedback loop (Ding et al.,
2013). In concordance with SNAI2 being a target of miR-203a, there
was reduced expression of SNAI2 when miR-203a was overexpressed in
D492M (Fig. 4F). Since the EMT phenotype has been associated with
apoptosis resistance and SNAI2 is a known inhibitor of apoptosis (Inoue
et al., 2002), we asked if D492MmiR-203a cells were less resistant to
chemically induced apoptosis compared to D492MEmpty. Indeed,
D492MmiR-203a cells were more sensitive than D492MEmpty to camp-
tothecin, a chemical inducer of apoptosis (Fig. 4G).
The ability of cells to proliferate as mammospheres under non-ad-
herent conditions has been described as a property of early progenitor/
stem cells (Dontu et al., 2003). When D492 and D492M were cultured
in low attachment plates both generated mammospheres but D492M
generated significantly larger and a higher number of colonies
(Sigurdsson et al., 2011). Interestingly, overexpression of miR-203a in
D492M negatively impacts anchorage independent growth, resulting in
loss of progenitor/stem cell properties indicating that miR-203a over-
expression in D492M induces cellular differentiation (Fig. 4H). As
mesenchymal cells have increased motility compared to epithelial cells,
we analyzed the effect of miR-203a overexpression on the ability of
D492M to migrate and invade. D492MmiR-203a cells showed reduced
ability to migrate through transwell filters (Fig. 4I, left) and to invade
through Matrigel coated transwell filters (Fig. 4I, right) indicating a
suppression of mesenchymal characteristics. Collectively, over-
expressing miR-203a in D492M induced a reduction of mesenchymal
characteristics, caused reduced proliferation, migration and invasion,
and increased sensitivity towards chemically induced apoptosis.
2.5. Peroxidasin (PXDN) is a novel target of miR-203a
Due to the phenotypic differences between D492 and D492M in 3D
culture and the fact that miR-203a is not expressed in D492M, we
decided to compare the transcriptional profiling of D492, D492M and
D492MmiR-203a, with emphasis on identifying novel targets of miR-
203a. Herein, we identified peroxidasin (PXDN), a collagen IV cross-
linking agent in the basement membrane, as the most significantly
downregulated gene in D492MmiR-203a compared to D492M (Fig. 5A).
In addition, we identified three potential binding sites for miR-203a in
the 3′-UTR of PXDN, one well conserved and two less conserved
(Fig. 5B). To further investigate the potential interaction between miR-
203a and PXDN we treated D492M and D492MmiR-203a with miR-203a-
mimic and miR-203a-inhibitor, respectively. PXDN expression was re-
duced (Fig. 5C, left) and increased (Fig. 5C, right) when D492M and
D492MmiR-203a were treated with miR-203a mimic and inhibitor, re-
spectively, corroborating that miR-203a regulates PXDN expression.
Furthermore, we demonstrated that PXDN expression was directly
regulated by miR-203a by carrying out a dual luciferase reporter assay
showing that the relative luciferase activity was significantly lower in
the PXDN 3′-UTR containing the miR-203a target sequence compared
with PXDN 3′-UTR with deleted miR-203a binding sequence, when
transfected with miR-203a mimic (***p < 0.001) (Fig. 5D). This sug-
gested that miR-203a could directly regulate the expression of PXDN
through targeting its 3′-UTR. As a positive control we demonstrated
significantly lower relative luciferase activity in p63 3′-UTR containing
the miR-203a target sequence compared with p63 3′-UTR with deleted
miR-203a binding sequence, when transfected with miR-203a mimic
(**p < 0.01) (Fig. S1).
In order to investigate whether the observed effect of miR-203a
overexpression on D492M is due to repression of PXDN, we knocked
down PXDN in D492M using siRNA (Fig. S2) and analyzed the phe-
notypic changes in monolayer. As with miR-203a overexpression, we
see reduced proliferation and increased sensitivity to chemically
Fig. 4. Overexpression of miR-203a in D492M.
A)Overexpression of miR-203a in D492M. RT-qPCR showing 17,500-fold expression of miR-203a in D492MmiR-203a compared to control.
B) MiR-203a increases adherence of D492M cells. Phase contrast images of monolayer cultures show that miR-203a overexpression in D492M causes cells to adhere
more to each other compared to D492MEmpty control. Phase contrast images from 3D culture show that D492MmiR-203a form more compact colonies, with some
colonies showing protrusion of mesenchymal cells compared to control. Scale bar= 100 μm.
C) MiR-203a reduces proliferation of D492M. Reduced proliferation of D492M shown by staining with crystal violet from day 1–7 in monolayer culture. Results are
shown as average of 4 replicates (mean ± SD)
D) DAB staining of monolayer cultures from D492MmiR-203a. D492MmiR-203a cells display reduced expression of N-Cadherin but show little change in expression of E-
Cadherin. Scale bar= 100 μm.
E) Western blot of E- and N-Cadherin in D492MmiR-203a. There is slightly less protein expression of N-Cadherin (10% reduction) but little change in expression of E-
Cadherin in D492MmiR-203a indicating reduced mesenchymal characteristics in D492MmiR-203a.
F) Expression of SNAI2 is reduced in D492MmiR-203a. MiR-203a, which has a known binding site in the 3′-UTR of SNAI2, significantly reduces expression of SNAI2 as
determined by qPCR.
G) D492MmiR-203a cells are more sensitive to chemically induced apoptosis. In D492M cells, miR-203a increases sensitivity to apoptosis induced by Camptothecin.
Data is analyzed on IncuCyte Zoom and data is displayed as Caspase 3/7 object count/mm2 (mean ± SEM).
H) Anchorage independent growth is reduced upon miR-203a overexpression. miR-203a reduces stem cell like properties in D492M. D492MmiR-203a has reduced
ability to generate mammospheres in low attachment assay compared to D492MEmpty.
I) MiR-203a reduces the ability of D492M cells to migrate and invade. D492MmiR-203a has less ability to migrate through trans-well filter than D492MEmpty and
D492MmiR-203a has reduced capability to invade through Matrigel coated transwell filter. Data is shown as average number of cells per field (mean ± SEM).
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Fig. 5. Gene expression profiling of D492M overexpressing miR-203a.
A) Volcano plot showing differential expressed transcripts in D492MmiR-203a and D492M, depicting statistical significance and high fold change in gene expression.
Volcano plot was constructed from RNA sequencing data using beta and q-values from Sleuth analysis (max FDR=0.05), enabling the visualization of the re-
lationship between differentially expressed transcripts and statistical significance. More extreme values on the x-axis show increased differential expression and
higher values on the y-axis show increased statistical significance. PXDN is the most downregulated gene when miR-203a is overexpressed in D492M.
B) PXDN 3′-UTR has three potential binding sites for miR-203a
Bioinformatics analysis reveals three potential binding sites for miR-203a in the 3′-UTR of PXDN a heme-containing peroxidase that is secreted into the extracellular
matrix and is involved in extracellular matrix formation. One of the binding sites is conserved and two are poorly conserved.
C) MiR-203a regulates PXDN expression. D492M cells treated with miR-203a mimic have reduced expression of PXDN, whereas D492MmiR-203a cells treated with
miR-203a inhibitor have increased expression of PXDN. Cells were treated with miR-203a-3p mimic or inhibitor, respectively, and PXDN expression was measured by
qPCR. Results are displayed as average of three independent experiments (mean ± sd, n= 3).
D) MiR-203a directly binds to its target sequence on PXDN 3′UTR. HEK293T cells transfected with miR-203a-3p mimic and pmirGLO plasmid containing the miR-
203a binding site and surrounding sequence had reduced luciferase activity compared to cells transfected with the miR-203a-3p mimic and plasmid with the miR-
203a binding site deleted, indicating binding of the miR-203a-3p mimic to the target sequence. Results are displayed as average of three independent experiments
(mean ± SD, n=3).
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induced apoptosis upon PXDN silencing (Fig. 6A & B), however no
changes were seen in migration nor invasion (data not shown). This
suggests that miR-203a mediates some of its effects, at least partly,
through repression of PXDN.
Collectively, we have shown that miR-203a is a novel repressor of
PXDN, a protein that plays an important role as a collagen IV cross-
linking agent in the basement membrane and has been implicated in the
EMT process, i.e. development, fibrosis and cancer.
3. Discussion
Modeling breast morphogenesis and EMT in 3D culture is an im-
portant tool to shed light on cellular and molecular mechanisms behind
these developmental events and complements well in vivo models.
Although animal models, in particular mouse models, have contributed
significantly to our understanding of mammary gland morphogenesis
and breast cancer, they cannot replace the necessity for using human
cells due to the molecular and cellular differences in mammary gland
biology between species (Dontu and Ince, 2015). Although, functionally
working in similar ways during breast feeding, the mouse and human
female mammary gland differ greatly. The human female breast gland
is composed of ducts that end in terminal duct lobular units (TDLUs),
surrounded by cellular-rich connective tissue. In contrast, the mouse
mammary gland is composed of ducts that terminate in end buds, which
are surrounded by adipose tissue. Thus, the histological comparison
between the mouse and human mammary gland demonstrates large
differences that need to be taken into account when studies are de-
signed to explore the interactions between epithelial cells and stroma.
In this study, we have applied two isogenic breast cell lines, D492
and D492M, and 3D culture based on reconstituted basement mem-
brane (rBM) to capture the phenotypic architecture of branching mor-
phogenesis of breast epithelium and EMT, respectively. D492 is a breast
epithelial progenitor cell line established from suprabasal epithelium of
a normal breast gland (Gudjonsson et al., 2002; Villadsen et al., 2007;
Sigurdsson et al., 2011). D492, was established by immortalizing cells
from reduction mammoplasty using the E6 and E7 oncogenes from
human papilloma virus 16. E6 and E7 target p53 and RB, respectively
that without any doubt interfere with number of processes in the cells
and this should be kept in mind when designing projects involving this
cell line. However, D492 is non-tumorigenic, can generate both luminal
and myoepithelial cells and in 3D culture generate structures re-
miniscent of TDLU-like structures in vivo and therefore remains a good
tool for studying molecular mechanisms involved in these processes.
D492M has a mesenchymal phenotype and is derived from D492 cells
that have undergone EMT when co-cultured with breast endothelial
cells (Sigurdsson et al., 2011).
In a previous work we demonstrated that overexpression of miR-
200c-141 in D492M was sufficient to induce MET in D492M albeit only
to luminal epithelial cells. When p63 was overexpressed in D492M
containing miR-200c-141, bipotential and branching properties of
D492 were restored (Hilmarsdottir et al., 2015). Recently, Wuidart
et al. showed that p63 was essential for maintaining the unipotent basal
fate of embryonic mouse mammary gland progenitors. Interestingly,
sustained p63 expression in luminal epithelial cells reprogrammed cells
towards basal cells (Wuidart et al., 2018). D492 has stem cell properties
based on its ability to generate luminal and myoepithelial cells in cul-
ture and branching structures in 3D culture. It is however, possible that
the immortalization using the E6 and E7 oncogenes from human pa-
pilloma virus 16 (Gudjonsson et al., 2002) and the 3D cell culture
condition may contribute to the cellular plasticity of D492 and thus
reflect more embryonic development of the mammary gland than
postnatal development.
In this study, we analyzed differential expression of miRNAs in
D492 and D492M on day 14 in 3D-rBM culture. Small RNA sequencing
analysis revealed 47 differentially expressed miRNAs between D492
and D492M at day 14 in culture, of which 20 miRNAs were down-
regulated in D492M. Among the most profound changes, was the
downregulation of the miR-200 family, miR-205 and miR-203a in
D492M. We have previously shown that these miRNAs are also down-
regulated in D492M when cultured in monolayer (Hilmarsdottir et al.,
2015) indicating a comparable expression pattern between 2D and 3D
conditions. In the same study we demonstrated that when miR-141 and
miR-200c, which are under regulation of the same promoter on chro-
mosome 12 (Hilmarsdottir et al., 2014; Hilmarsdottir et al., 2015), were
overexpressed in D492M, a reversal towards epithelial phenotype was
induced, albeit only towards the luminal epithelial phenotype
(Hilmarsdottir et al., 2015). Unlike miR-200c-141 and miR-205, which
are both heavily methylated in D492M, we did not observe any me-
thylation of CpG islands in the promoter area of miR-203a. The un-
methylated pattern of the miR-203a promoter in D492M is opposite to
what has been described in other breast cell lines with a mesenchymal
phenotype (Zhang et al., 2011; Taube et al., 2013). This indicates that
miR-203a down regulation in D492M may be through other processes,
such as histone modification, or transcription factor repression.
Ectopic overexpression of miR-203a in D492M partially induced
epithelial traits. The effect of increased miR-203a expression was
Fig. 6. PXDN repression reduces proliferation and increases sensitivity to chemically induced apoptosis.
A) PXDN silencing in D492M cells reduces proliferation. D492M cells treated with siRNA against PXDN have reduced proliferation rate compared to D492M cells
treated with negative control siRNA or untreated D492M cells. Data is analyzed on IncuCyte Zoom and data is displayed as Confluency percentage (mean ± SEM).
B) D492M cells with silenced PXDN are more sensitive to chemically induced apoptosis. Camptothecin induced apoptosis is increased in D492M cells with silenced
PXDN, compared to cells treated with negative control siRNA and untreated D492M cells. Data is analyzed on IncuCyte Zoom and data is displayed as Caspase 3/7
object count/mm2 (mean ± SEM).
E. Briem et al. Mechanisms of Development 155 (2019) 34–47
42
primarily evident in functional assays, where it caused reduced cell
proliferation, migration, and invasion. Morphologic and gene expres-
sion changes were subtle and indicated only partial MET, as evidenced
by reduced expression of N-cadherin, and SNAI2, an EMT transcription
factor known to silence expression of miR-203a. Moes et al. demon-
strated that overexpression of SNAI1 in MCF-7 breast cancer cells re-
sulted in repression of miR-203 (Moes et al., 2012).
Branching morphogenesis of the D492 cells in 3D-rBM was used to
mimic breast development and differentiation. We show that miR-203a
expression coincides with increased differentiation status of the breast
epithelial cells. In contrast, other epithelial associated miRNAs such as
miR-205, miR-200c and miR-141 show constant or minimal fluctuation
in expression throughout the branching period (21 days). In a miRNA
expression study on mouse mammary gland development, Avril-Sassen
et al. (2009) demonstrated that miR-203a showed temporal changes
during different phases of mammary gland development. High expres-
sion was seen in early development and gestation followed by low ex-
pression in lactation and involution stages (Avril-Sassen et al., 2009).
Reduced expression of miR-203a in lactation might be due to that fact
that lactation requires functionally active p63 positive myoepithelial
cells. MiR-203a is a repressor of p63 and therefore, downregulation of
miR-203a is probably necessary for full activity of the myoepithelium.
Since D492 cells have stem cell properties, it is possible to separate
cells into luminal epithelial and myoepithelial cells (Gudjonsson et al.,
2002; Villadsen et al., 2007). Based on EpCAM, a luminal associated
epithelial adhesion molecule, we separated D492 cells into two cell
populations: EpCAM-high and EpCAM-low. EpCAM-high cells showed
significantly higher expression of miR-203a than EpCAM-low cells. This
was also confirmed in primary luminal epithelial- and myoepithelial
cells. This result is in agreement with DeCastro et al. (DeCastro et al.,
2013), where they demonstrated that miR-203a was significantly more
expressed in mouse luminal epithelial progenitor cells and differ-
entiated luminal epithelial cells compared to stem/basal cells. They also
tested the expression levels of miR-203a in a number of normal and
cancerous human breast epithelial cell lines: highest expression was
predominantly in cell lines with a luminal epithelial phenotype.
To search for potential target genes for miR-203a we analyzed gene
expression of D492M and D492MmiR-203a. The most significantly dif-
ferential expressed gene between D492M and D492MmiR-203a was
PXDN. PXDN is a heme-containing peroxidase that produces hypo-
bromous acid (HOBr) to form sulfilimine cross-links to stabilize the
collagen IV network in the basement membrane and is believed to be
important in normal development (Colon et al., 2017). PXDN has also
been linked to EMT and disease conditions such as melanoma invasion
and fibrosis (Tindall et al., 2005; Cheng et al., 2008; Peterfi et al., 2009;
Liu et al., 2010; Tauber et al., 2010; Barnett et al., 2011; Khan et al.,
2011; Bhave et al., 2012; Yan et al., 2014; Ero-Tolliver et al., 2015;
Colon and Bhave, 2016; Jayachandran et al., 2016; Sitole and Mavri-
Damelin, 2018).
Jayachandran et al. identified PXDN as consistently elevated in in-
vasive mesenchymal-like melanoma cells and it was also found highly
expressed in metastatic melanoma tumors. Gene silencing led to re-
duced melanoma invasion in vitro (Jayachandran et al., 2016). More-
over, Peterfi et al. have shown that PXDN is secreted from myofibro-
blasts and also from fibrotic kidney (Peterfi et al., 2009). Young et al.
demonstrated that PXDN expression increases in PIK3CA mutant
MCF10A cells and that the PXDN protein is mainly associated with
secreted exosomes (Young et al., 2015). When knocking down PXDN in
four basal like breast cancer cell lines, all cell lines showed reduced
proliferation and when PXDN was knocked down in the luminal cell
line MDA-MB-361, which expresses little PXDN, there was also reduced
proliferation (Young et al., 2015). The reduced proliferation rate we
saw in D492MmiR-203a, could be because of PXDN silencing by miR-
203a, as we also see reduced proliferation when PXDN is transiently
knocked down with silencing RNA. The fact that PXDN is overexpressed
in the mesenchymal cell line D492M may link it to the EMT phenotype.
In summary, mammary gland development is mostly a post-natal
process, where post-transcriptional regulation via miR-203a expression
correlates with differentiation stages in the mammary epithelium.
Using the D492 breast progenitor cells cultivated in 3D-rBM it is pos-
sible to capture the critical aspects of branching morphogenesis.
Temporal changes in miR-203a expression during the in vitro branching
process correlate well with in vivo conditions. Although miR-203a re-
pression and overexpression are well documented in a number of stu-
dies, we observed only subtle changes towards MET when over-
expressed in D492M. Furthermore, we have demonstrated a novel link
between miR-203a and PXDN, which is highly expressed in D492M.
Collectively, we conclude that miR-203a may be important to retain
epithelial phenotype of breast epithelial cells, possibly through its
target PXDN.
4. Material and methods
4.1. Cell culture
D492 and D492M cells were maintained in H14 medium as de-
scribed previously (Sigurdsson et al., 2011). Primary luminal epithelial
cells (EpCAM+) and myoepithelial cells (EpCAM−) were isolated from
primary culture of breast epithelial cells derived from reduction
mammoplasties by magnetic cell sorting (MACS) and maintained in
CDM3 and CDM4, respectively, as previously described (Pechoux et al.,
1999). Primary human breast endothelial cells (BRENCs) were isolated
from breast reduction mammoplasties and cultured in endothelial
growth medium (EGM) (Lonza)+ 5% FBS (Invitrogen), referred to as
EGM5 (Sigurdsson et al., 2006). Growth factor reduced reconstituted
basement membrane (rBM, purchased as Matrigel, Corning #354230)
was used for 3D cultures. 3D monocultures were carried out in 24-well
culture plates (Corning). 1× 104 D492 cells were suspended in 300 μl
of rBM. Co-culture experiments were carried out with either 500, or
1× 103 cells mixed with 1× 105–2×105 BRENCs. 300 μl of mixed
cells/rBM were seeded in each well of a 24-well plate and cultured on
H14 (monoculture) or EGM5 (co-culture) for 14–21 days.
Branching, solid and spindle-like structures were isolated from 3D
co-cultures with gentle shaking on ice in PBS - EDTA (5mM) solution as
previously described (Lee et al., 2007).
4.2. Small RNA sequencing
Total RNA was isolated from branching and spindle-like colonies
from D492 and D492M, respectively using Tri-Reagent (Thermo Fisher
Scientific, #AM9738). For D492 branching time points, RNA was iso-
lated from 3D-rBM culture on days 7, 14 and 21 but for D492M RNA
was isolated only on day 14. Samples were pooled in triplicates from
each time point before small RNA library preparation. Small RNA li-
braries were prepared using the TruSeq Small RNA Library Kit from
Illumina (#RS-200-0012) per manufacturer's protocol. The small RNA
libraries were then sequenced using the Illumina MiSeq platform and
V2 sequencing chemistry. FASTQ files were generated with MiSeq
Reporter (Illumina, San Diego, US-CA). Small RNA sequence analysis
was performed using the CLC Genomics Workbench (CLC Bio-Qiagen,
Aarhus, Denmark) and miRBase – release 21 was used for annotation.
Samples were normalized by totals and counts reported as reads per
million. Reads above 29 nt and below 15 nt in length were discarded.
Proportion-based statistical analysis was done using the test of Kal (Kal
et al., 1999). Hierarchal clustering of features was performed using
Log2 transformed expression values, Euclidean distance and single
linkage. For the D492 and D492M comparison samples from day 7, 14
and 21 from D492 were compared to D492M sample from day 14.
4.3. DNA isolation and methylation bead chip array
D492 (1× 104 cells) and D492M (2.5×104 cells) were grown in
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3D-rBM in triplicate in a 24-well plate for 14 days and colonies ex-
tracted from 3D-rBM with gentle shaking on ice in PBS - EDTA (5mM)
solution as previously described (Lee et al., 2007). DNA was extracted
using the PureLink Genomic DNA Mini Kit (Thermo Fisher Scientific,
#K182002) and DNA was bisulfite converted using the EZ-96 DNA
Methylation-Gold Kit (Zymo Research, #D5007) per manufacturer's
protocols. The samples were hybridized to the Infinium Hu-
manMethylation450 BeadChip array (Illumina, # WG-314-1003). Data
was analyzed using the minfi Bioconductor package (Aryee et al.,
2014).
4.4. Bisulfite sequencing
DNA (0.5–1 μg) was bisulfite converted using the EpiTect Bisulfite
Kit (Qiagen, #59104). Target DNA sequences were amplified using
nested PCR (see primers in Table S1). Methylation levels were analyzed
by sequencing the bisulfite modified promoter regions on a 3130
Genetic Analyzer (Applied Biosystems). Methylation data from bisulfite
sequencing was analyzed and visualized using the BiQ Analyzer v2.0
(Bock et al., 2005).
4.5. Quantitative reverse transcription PCR analysis
Total RNA was extracted with Tri-Reagent (Thermo Fisher
Scientific, #AM9738) and
reverse transcription performed using random hexamers (Thermo
Fisher Scientific, #N8080127) and SuperScript IV Reverse
Transcriptase (Thermo Fisher Scientific, #18090050). The following
primers were used for mRNA qRT-PCR analysis, SNAI2
(Hs00950344_m1) (Thermo Fisher Scientific, #4331182) and GAPDH
as endogenous reference gene (Thermo Fisher Scientific, # 4326317E).
Maxima Probe/ROX qPCR Master Mix (2×) (Thermo Fisher Scientific,
# K0231) was used for TaqMan qRT-PCR analysis.
Quantitative RT-PCR analysis of miRNAs was performed using the
universal cDNA synthesis kit II (Exiqon, #203301) and ExiLENT SYBR
Green master mix (Exiqon, #203402). The following primer sets from
Exiqon were used for miRNA qRT-PCR analysis, hsa-miR-203a
(#205914), hsa-miR-141-3p (#204504), hsa-miR-200c-3p (#204482),
hsa-miR-205-5p (#204487) and U6 snRNA (#203907) was used as
endogenous reference. All qRT-PCRs were performed on the Applied
Biosystems 7500 Real-Time PCR system and relative expression dif-
ferences were calculated with the 2ΔCt method.
4.6. Cloning of miR-203a into pCDH lentivector
The miR-203a miRNA construct was amplified from D492 genomic
DNA using nested PCR with the following outer primers, miR-203a-
outer-F 5′-ATCAGTCGCGGGACCTATG-3′ and miR-203a-outer-R
5′-GAATTCCACGGAGTTTCGAG-3′. From miR-203a-outer amplicon,
EcoRI and NotI restriction sites were incorporated with PCR using the
following inner primers, miR-203a-EcoRI-F-5′-TAAGCAGAA
TTCaggcgagggcgtctaagg-3′ and miR-203a-NotI-R-5′-TGCTTAGCGGC
CGCacctcccagcagcacttg-3′. Phusion High-Fidelity DNA Polymerase
(NEB, # M0530S) was used for PCR and amplicons were purified using
the GeneJET PCR purification kit (Thermo Fisher Scientific, #K0701).
Double digestions of miR-203a-inner amplicon and pCDH vector
(System Biosciences, #CD516B-2) were performed using EcoRI (NEB,
#R0101) and NotI (Thermo Fisher Scientific, #ER0591). The miR-
203a-inner amplicon was cloned into pCDH lentivector at insert-to-
vector molar ratio 10:1 using T4 DNA ligase (Thermo Fisher Scientific,
#15224041). Empty pCDH lentivector and miR-203a-pCDH lentivector
were transformed into E. coli DH5alpha competent cells and inserts
confirmed with colony PCR. Lentivectors were produced in cultures of
DH5alpha and isolated using GeneJET Plasmid Miniprep kit (Thermo
Fisher Scientific, #K0502). The cloned miR-203a insert sequence was
then confirmed with sequencing. The pCDH lentivector has a RFP
+Puro fusion containing the T2A element to enable co-expression of
balanced levels of RFP and Puro genes. Viral particles were produced in
HEK-293 T cells using TurboFect transfection reagent (Thermo Fisher
Scientific, #R0531) and virus containing supernatant collected after 48
and 72 h, centrifuged and filtered through 0.45 μm filter. Target cells
were transfected with virus titer in the presence of 8 μg/μl polybrene.
Stable cell lines and control (empty-lentivector) cells were isolated with
puromycin (2 μg/ml) (Thermo Fisher Scientific, # A1113803) followed
by flow-sorting (Sony SH800), selecting for RFP expressing cells.
4.7. Immunochemistry
The following primary antibodies were used for DAB staining (Dako,
# K3467), E-cadherin (BD, # 610182), N‑cadherin (BD, # 610921),
K14 (Abcam, #ab7800) and K19 (Abcam, #ab7754). Specimens were
visualized on a Leica DMI3000 B inverted microscope.
4.8. Western blotting
Equal amounts (5 μg) of proteins in RIPA buffer were separated on
NuPAGE™ 10% Bis-Tris Protein Gels (Thermo Fisher Scientific,
#NP0302BOX) and transferred to a PVDF membrane (Millipore,
#IPFL00010). Antibodies: SNAI2 (Cell Signaling, #9585) and Histone
H3 (Cell Signaling, #4499). Secondary antibodies were mouse or rabbit
IRDey (Li-Cor) used at 1:20,000 and detected using the Odyssey
Infrared Imaging System (Li-Cor). Fluorescent images were converted
to gray scale.
4.9. Proliferation assay
Cells were seeded in triplicates in 24-well plates and cultures
stopped every 24 h. Cells were fixed in 3.7% formaldehyde in PBS for
10min, washed once with 1 x PBS, stained with 0.1% crystal violet in
10% ethanol for 15min, washed four times with water and dried.
Density of cells was evaluated by extracting the crystal violet stain in
10% acetic acid and measuring optical density at 595 nm using a
spectrometer. In addition, proliferation rate of D492M cells treated with
siRNA was analyzed on IncuCyte Zoom (Essen Bioscience) per manu-
facturer's instructions.
4.10. Apoptosis assay
Resistance to chemically induced apoptosis with 10 μM camp-
tothecin (Sigma-Aldrich, #C9911) was determined using IncuCyte
Caspase-3/7 Reagents (Essen Bioscience, #4440) and imaging on
IncuCyte Zoom (Essen Bioscience) per manufacturer's instructions.
4.11. Anchorage independence, migration and invasion assays
Anchorage independent growth was determined using 24-well ultra-
low attachment plates (Corning, #3473), where triplicates of 500 cells
of D492MmiR-203a and D492MEmpty were single cell filtered and cultured
using EGM5 medium for 9 days.
For migration analysis, triplicates of 10,000 starved D492MmiR-203a
and D492MEmpty cells were seeded in DMEM/F12, HEPES medium
(Thermo Scientific, #31330038) on collagen I (Advanced BioMatrix,
#5005-B) coated transwell filters with 8 μm pore size (Corning,
#353097) with EGM5 medium in the lower chamber and incubated for
24 h. Filters were rinsed with 1×PBS and cells on the apical layer
wiped off with a cotton swab (Q-tip) and migrated cells fixed in 3.7%
formaldehyde in PBS for 10min, washed with 1×PBS, stained with
0.1% crystal violet in 10% ethanol for 15min and washed with water
and then dried. Images were acquired and migrated cells counted, 3
images per filter.
Invasion assay was performed using transwell filters with 8 μm pore
size (Corning, #353097) that were coated with 100 μl diluted Matrigel
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(Corning, #354230) 1:10 in H14 media. D492MmiR-203a and
D492MEmpty (25,000 cells) were seeded in H14 media on top of
Matrigel coated filters and H14+5% FBS added to the lower chamber
and incubated for 44 h. Matrigel was then removed with a cotton swab
and washed with PBS. Cells were fixed in 3.7% formaldehyde in PBS for
15min and washed four times with water. Images were acquired and
migrated cells counted, 3 images per filter.
4.12. PolyA mRNA sequencing and analysis
RNA was isolated from 3D and 2D cultures using the Exiqon
miRCURY RNA Isolation Kit - Cell and Plant and quality control of RNA
samples was performed using BioAnalyzer. Libraries were prepared
using polyA mRNA library kit from Illumina and sequenced on a HiSeq
sequencer from Illumina. Alignment of reads and annotation was per-
formed using Kallisto (Bray et al., 2016) and differential expression
analysis was done using Sleuth (Pimentel et al., 2017).
4.13. Transient transfection with miR-203a mimic
Briefly, D492M cells were separately transfected with 50 pmol of
mirVANA miR-203a-3p mimic (Thermo Fisher, #4464066, Assay ID
MC10152) and miRNA mimic negative control #1 (Thermo Fisher,
#4464058) using RNAiMAX (Thermo Fisher, #13778075) per manu-
facturer's instructions for mirVana miRNA mimics.
4.14. Transient transfection with miR-203a inhibitor
Briefly, D492MmiR-203a cells were separately transfected with
50 pmol of mirVANA miR-203a-3p inhibitor (Thermo Fisher, #
4464084, Assay ID MH10152) and mirVana miRNA Inhibitor, Negative
Control #1 (Thermo Fisher, # 4464076) using RNAiMAX (Thermo
Fisher, #13778075) per manufacturer's instructions for mirVana
miRNA inhibitors.
4.15. Plasmid vector constructs and Luciferase activity assay
Synthetic oligonucleotides containing the hsa-miR203a-3p target
sequence of human PXDN 3′-UTR (Position 106–113) or a deletion
thereof (Table 1) were cloned into pmirGLO Dual-Luciferase miRNA
Target Expression Vector (Promega Corporation, Madison, WI, USA). As
a positive control we cloned the target sequence of p63 3′-UTR, a
known hsa-miR203a-3p target, into pmirGLO, as well as a mismatched
version of the p63 target site or a deletion thereof (Fig. S1). Correct
sequence and orientation was verified by DNA sequencing (Eurofins
Genomics, Ebersberg, Germany).
HEK293T cells were plated in a 96-well plate 3.0×104per well and
incubated overnight. Cells were first transfected with hsa-miR203a-3p
mimics (mirVana™ miRNA Mimics, Thermo Fisher Scientific,
#4464070) with final concentration of 100 nM, using Lipofectamine
RNAiMAX (Thermo Fisher Scienttific, #13778150) transfection reagent
(according to manufacturer's instructions, with minor changes: using
serum free and antibiotic-free high glucose DMEM medium instead of
Opti-MEM® Medium). 24 h after transfection with miRNA mimics, cells
were transfected (according to manufacturer's instructions) with
200 ng/well luciferase plasmids (pmirGLO constructs), using
Lipofectamine 3000 (Thermo Fisher Scientific, #L3000015). After 24 h,
plasmid-transfection cells were analyzed for luciferase activity using
the Dual-Glo® Luciferase Assay System (Promega Corporation, Madison,
WI, USA). Results are displayed as normalized firefly luciferase activity
(background subtracted firefly luciferase activity/background sub-
tracted renilla luciferase activity) for each construct. For each trans-
fection, luciferase activity was averaged from four replicates, and three
independent experiments were performed.
4.16. Transient transfection with siRNA
D492M cells were transfected with 10 nm final concentration of
negative control siRNA (SilencerSelect siRNA #4390843, Ambion) and
siRNA targeting PXDN (SilencerSelect siRNA #4427037, Ambion),
using Lipofectamine RNAiMAX (Thermo Fisher Scienttific,
#13778150), according to the manufacturer's protocol. Cells were in-
cubated for 48 h and then the knockdown was confirmed by qRT-PCR
using the following primers; Hs.PT.58.630748 (PrimeTime, IDT).
4.17. Statistics
All analyses comprised at least three independent experiments.
Two-tailed student t-test was used to test significance (p < 0.05).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.mod.2018.11.002.
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Synthetic oligonucleotides containing the hsa-mir-203a-3p target sequence of human PXDN 3′-UTR/p63 3′-UTR or a
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